Contact us on (02) 8445 2300
For all customer service and order enquiries

Woodslane Online Catalogues

9781615375530 Academic Inspection Copy

Good Psychiatric Management for Borderline Personality Disorder and Alcohol Use Disorder

  • ISBN-13: 9781615375530
  • Publisher: AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING
    Imprint: AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING
  • Edited by Lois W. Choi-Kain, Edited by Hilary Connery
  • Price: AUD $159.00
  • Stock: 0 in stock
  • Availability: This book is temporarily out of stock, order will be despatched as soon as fresh stock is received.
  • Local release date: 03/10/2024
  • Format: Paperback (229.00mm X 152.00mm) 277 pages Weight: 0g
  • Categories: Psychiatry [MMH]
Description
Google
Preview

Six percent of people in North America will develop borderline personality disorder (BPD) in their lifetime, and about 46% of BPD patients will also have alcohol use disorder (AUD). Alcohol use exacerbates the symptoms of both diseases, rendering treatment more challenging and increasing the risk of suicide. Integrated treatments have been lacking.

Good Psychiatric Management for Borderline Personality Disorder and Alcohol Use Disorder meets the urgent need for such an integrated approach. It provides clearly articulated descriptions of both BPD and AUD, pointing out clinical patterns and how to diagnose with confidence. Relying on general psychiatric principles with which most clinicians are already familiar, as well as up-to-date standards of care for both BPD and AUD, the handbook pays particular attention to areas of potential synergy, providing clinical logic for addressing complex, real-world cases.

Topics include the following:
 

  • Progress assessment, psychoeducation, and goal setting.
  • Managing suicidality and nonsuicidal self-harm.
  • Pharmacotherapy.
  • Multimodal treatments, including group therapy and family intervention.
  • Level-of-care considerations.

  • The authors stress that, in the absence of manualized therapy for BPD and AUD, clinicians already have the tools to increase treatment retention, reduce the risk of suicide and death, and provide a sensible road map in the face of interpersonal, behavioral, and emotional challenges inherent to recovery for both conditions.
Google Preview content